Cytochalasin H, an Active Anti-angiogenic Constituent of the Ethanol Extract of Gleditsia sinensis Thorns
Author:
Affiliation:
1. KM-Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Link
https://www.jstage.jst.go.jp/article/bpb/37/1/37_b13-00318/_pdf
Reference37 articles.
1. ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
2. Tumor Angiogenesis: Therapeutic Implications
3. 3) Los M, Roodhart JM, Voest EE. Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist, 12, 443–450 (2007).
4. 4) Lord S, Harris AL. Angiogenesis-still a worthwhile target for breast cancer therapy? Breast Cancer Res., 12 (Suppl. 4), S19 (2010).
5. 5) Lee SJ, Ryu DH, Jang LC, Cho SC, Kim WJ, Moon SK. Suppressive effects of an ethanol extract of Gleditsia sinensis thorns on human SNU-5 gastric cancer cells. Oncol. Rep., 29, 1609–1616 (2013).
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Gleditsia sinensic extract as green corrosion inhibitor for N80 steel in 1 M HCl;Journal of Molecular Structure;2025-02
2. Gleditsia sinensis Lam. aqueous extract attenuates nasal inflammation in allergic rhinitis by inhibiting MUC5AC production through suppression of the STAT3/STAT6 pathway;Biomedicine & Pharmacotherapy;2023-05
3. Immunosuppressive Cytochalasins from the Mangrove Endophytic Fungus Phomopsis asparagi DHS-48;Marine Drugs;2022-08-18
4. Profiling of widely targeted metabolomics for the identification of chemical composition in epidermis, xylem and pith of Gleditsiae Spina;Biomedical Chromatography;2022-03-11
5. GT198 Is a Target of Oncology Drugs and Anticancer Herbs;Frontiers in Oral Health;2021-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3